Latest News, Grants & Research Reports

Read our latest news, blog posts and research updates right here

Let's welcome 2024 with a hug
Guest User Guest User

Let's welcome 2024 with a hug

We know that the start of a New Year can be challenging, especially for those who have lost loved ones. At Neuroblastoma UK, we are sending our kindest thoughts to anyone struggling.  Thank you so much for your ongoing support which allows us to not only connect with you, but also to continue funding research into new, more effective and less punishing treatments for children with neuroblastoma.

Read More
Thank you for your support in 2023
latest news Guest User latest news Guest User

Thank you for your support in 2023

Thank you for supporting Neuroblastoma UK in 2023.

As we draw closer to the end of a busy but exciting year, all of us at Neuroblastoma UK would like to thank you for your support in the fight against childhood cancer. Here are some of our highlights from the year.

Read More
big give, latest news, fundraising Guest User big give, latest news, fundraising Guest User

Big donations for the Big Give Christmas Challenge

For the first time, Neuroblastoma UK took part in the Big Give Christmas Challenge 2023. We raised a grand total to £8,602 in just seven days.

We were blown away by everyone’s support, thank you. The money raised from the Big Give Christmas Challenge will enable scientists to take crucial first steps on the road of discovery - and help get closer to a cure for neuroblastoma.

Read More
Holyrood reception to raise awareness of childhood cancer
latest news, press release Guest User latest news, press release Guest User

Holyrood reception to raise awareness of childhood cancer

Neuroblastoma UK attended Holyrood on Tuesday 26 September, calling on MSPs to ensure childhood cancer is recognised as a critical research priority in Scotland.

The reception, hosted by Rona Mackay MSP for Strathkelvin and Bearsden, was held in memory of two-year-old Matthew Innes to raise awareness of neuroblastoma, a rare and aggressive childhood cancer.

Read More